OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic potential and functional interaction of carfilzomib and vorinostat in T-cell leukemia/lymphoma
Minjie Gao, Gege Chen, Houcai Wang, et al.
Oncotarget (2016) Vol. 7, Iss. 20, pp. 29102-29115
Open Access | Times Cited: 22

Showing 22 citing articles:

ASGARD is A Single-cell Guided Pipeline to Aid Repurposing of Drugs
Bing He, Yao Xiao, Haodong Liang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 28

Canagliflozin mitigates carfilzomib-induced endothelial apoptosis via an AMPK-dependent pathway
Mohamed S. Dabour, Ibrahim Y. Abdelgawad, Marianne Grant, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114907-114907
Open Access | Times Cited: 20

Histone deacetylase inhibitors for leukemia treatment: current status and future directions
Mohammad‐Salar Hosseini, Zohreh Sanaat, Mohammad Amin Akbarzadeh, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 4

Expression of H3K4me3 and H3K9ac in breast cancer
Luisa Berger, Thomas Kolben, Sarah Meister, et al.
Journal of Cancer Research and Clinical Oncology (2020) Vol. 146, Iss. 8, pp. 2017-2027
Open Access | Times Cited: 30

Recent Research Progress of Chiral Small Molecular Antitumor-Targeted Drugs Approved by the FDA From 2011 to 2019
Xuetong Chu, Yizhi Bu, Xiaoping Yang
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 19

New directions in treating peripheral T-cell lymphomas (PTCL): leveraging epigenetic modifiers alone and in combination
Helen Ma, Owen A. O’Connor, Enrica Marchi
Expert Review of Hematology (2019) Vol. 12, Iss. 3, pp. 137-146
Closed Access | Times Cited: 17

Carfilzomib induces G2/M cell cycle arrest in human endometrial cancer cells via upregulation of p21Waf1/Cip1 and p27Kip1
Yuanyuan Zhou, Ke Wang, Shuai Zhen, et al.
Taiwanese Journal of Obstetrics and Gynecology (2016) Vol. 55, Iss. 6, pp. 847-851
Open Access | Times Cited: 14

Mitogen-activated protein kinases are involved in cucurbitacin D-induced antitumor effects on adult T-cell leukemia cells
Duo Wang, Mengyue Shen, Noriaki Kitamura, et al.
Investigational New Drugs (2020) Vol. 39, Iss. 1, pp. 122-130
Closed Access | Times Cited: 13

Preclinical activity of DCZ3301, a novel aryl-guanidino compound in the therapy of multiple myeloma
Minjie Gao, Bo Li, Xi Sun, et al.
Theranostics (2017) Vol. 7, Iss. 15, pp. 3690-3699
Open Access | Times Cited: 13

NLRP3 Is Expressed in the Spiral Ganglion Neurons and Associated with Both Syndromic and Nonsyndromic Sensorineural Deafness
Penghui Chen, Longxia He, Xiuhong Pang, et al.
Neural Plasticity (2016) Vol. 2016, pp. 1-6
Open Access | Times Cited: 12

Synergistic effects of vorinostat (SAHA) and azoles against Aspergillus species and their biofilms
Bo Tu, Gendi Yin, Hui Li
BMC Microbiology (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 11

Proteasome inhibition as a therapeutic approach in atypical teratoid/rhabdoid tumors
Andrew Morin, Caroline Soane, Angela Pierce, et al.
Neuro-Oncology Advances (2020) Vol. 2, Iss. 1
Open Access | Times Cited: 11

Varinostat Alters Gene Expression Profiles in Aortic Tissues from ApoE−/–Mice
Yicong Ye, Xiliang Zhao, Yi-yun Lu, et al.
Human Gene Therapy Clinical Development (2018) Vol. 29, Iss. 4, pp. 214-225
Closed Access | Times Cited: 11

Inhibitory effects of vorinostat (SAHA) against food-borne pathogen Salmonella enterica serotype Kentucky mixed culture biofilm with virulence and quorum-sensing relative expression
Pantu Kumar Roy, Angela Ji-Won Ha, Shamsun Nahar Begum, et al.
Biofouling (2023) Vol. 39, Iss. 6, pp. 617-628
Closed Access | Times Cited: 3

Adipocyte-mediated epigenomic instability in human T-ALL cells is cytotoxic and phenocopied by epigenetic-modifying drugs
Mi-Young Lee, Delaney K. Geitgey, Jamie A.G. Hamilton, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 3

Carfilzomib-Loaded Ternary Polypeptide Nanoparticles Stabilized by Polycationic Complexation
Preye Agbana, Ji Eun Park, Piotr G. Rychahou, et al.
Journal of Pharmaceutical Sciences (2023) Vol. 113, Iss. 3, pp. 711-717
Open Access | Times Cited: 1

Therapeutic approaches for relapsed/refractory adult acute lymphoblastic leukemia (ALL), a review on monoclonal antibodies and targeted therapies
Maryam Hosseini, Leila Jafari, Amir Yami, et al.
Indian Journal of Cancer (2022) Vol. 59, Iss. 1, pp. 4-11
Closed Access | Times Cited: 1

ASGARD: A Single-cell Guided pipeline to Aid Repurposing of Drugs
Bing He, Lana X. Garmire
arXiv (Cornell University) (2021)
Open Access | Times Cited: 1

Small Molecule Inhibitors That Target Signal Transduction Pathways Involved In Oxidative Stress-Induced Cancer
Naveen Kumar Perumal, Nivya Vijayan, Madan Kumar Perumal, et al.
Handbook of Oxidative Stress in Cancer: Therapeutic Aspects (2022), pp. 1-14
Closed Access

Small Molecule Inhibitors That Target Signal Transduction Pathways Involved in Oxidative Stress-Induced Cancer
Naveen Kumar Perumal, Nivya Vijayan, Madan Kumar Perumal, et al.
Handbook of Oxidative Stress in Cancer: Therapeutic Aspects (2022), pp. 761-773
Closed Access

Innovative Chemotherapy‐free Approaches for the Treatment of Peripheral T‐Cell Lymphoma
Enrica Marchi, Ahmed Sawas, Helen Ma, et al.
(2021), pp. 367-377
Closed Access

Page 1

Scroll to top